Ophtesic (Anhydrous Lidocaine Hydrochloride)

Lidocaine, the active ingredient in Ophtesic, is a local anesthetic presented as a sterile ophthalmic solution for topical ocular use. It provides rapid, reversible numbness of the cornea and conjunctiva, facilitating pain‑free examinations and minor procedures in patients of all ages.

GNH USA supplies Ophtesic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Customers benefit from reliable logistics, batch traceability, and responsive technical support throughout the supply chain.

Ophtesic, containing lidocaine, provides topical anesthesia for ocular surface procedures and examinations.

- Corneal abrasion: relieves pain and discomfort during healing. - Intra‑ocular surgery: numbs the ocular surface to facilitate safe instrument insertion. - Diagnostic eye examinations: reduces stinging from fluorescein staining and other diagnostic agents.

Adverse ocular reactions to Ophtesic are generally mild, but rare serious events can occur.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision. - Conjunctival hyperemia. - Excessive tearing.

Serious or Rare Side Effects: - Allergic reaction with eyelid edema or angioedema. - Corneal epithelial damage. - Increased intra‑ocular pressure. - Systemic toxicity presenting as CNS symptoms such as dizziness or seizures.

Before using Ophtesic, consider the following precautions to ensure safe and effective application.

- Allergy assessment: avoid in patients with known lidocaine hypersensitivity. - Ocular infection: defer use until active infection has been treated. - Contact lens wearers: remove lenses prior to instillation and wait before reinserting. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Pediatric use: dosage and frequency should be determined by an ophthalmologist. - Store at room temperature: keep in the original container, protect from light and moisture.

Ophtesic may interact with certain systemic and topical agents; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Class I antiarrhythmic drugs (e.g., quinidine, procainamide): risk of additive cardiotoxicity. - Concurrent use of other local anesthetics: potential for cumulative lidocaine toxicity. - Systemic central nervous system depressants (e.g., barbiturates, benzodiazepines): enhanced CNS depression.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask early signs of lidocaine toxicity. - Calcium channel blockers: can increase plasma lidocaine concentrations. - Epinephrine‑containing ophthalmic solutions: may alter lidocaine absorption and prolong effect.